Lv61
2370 积分 2023-03-01 加入
Advancing Allogenic Cell Therapy with Automated iPSC Processing and Engineering: Benefits of a Closed Modular Approach
2个月前
已关闭
Trends in the development of cellular and gene therapy in China
3个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
3个月前
已完结
GMP-grade microcarrier and automated closed industrial scale cell production platform for culture of MSCs
3个月前
已完结
Advanced Quality by Design (QbD) Approach to Large-Scale GMP Manufacturing of Mesenchymal Stem/Stromal Cells for Clinical Applications
3个月前
已完结
GMP-compliant manufacturing of iPSC-derived therapeutic cell products: Technologies, applications, risks and limitations
3个月前
已完结
ORGAN-SPECIFIC DELIVERY OF AN MRNA-ENCODED BISPECIFIC T CELL ENGAGER TARGETING GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
6个月前
已完结
How good enough are the new therapies for lupus nephritis? A narrative review and a position paper
6个月前
已关闭
CAR T-cell therapy in SLE: A systematic review
8个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
8个月前
已完结
皖公网安备34019202002308
